Diffuse Bio

Diffuse Bio is pioneering the use of generative AI to engineer new and useful proteins with unprecedented control and accuracy. Their platform leverages deep learning models trained on massive biological datasets to design proteins for a wide range of applications, from therapeutics to diagnostics and beyond. By combining expertise in biology and artificial intelligence, Diffuse Bio aims to accelerate the discovery and development of protein-based solutions, moving the process from traditional lab work to advanced computational design.

The company’s core technology includes proprietary AI models, such as DSG2 and DSG2-mini, which are capable of generating 3D protein structures and designing protein binders that target specific regions of interest. These models outperform previous industry standards and open-source alternatives, offering higher hit rates and greater specificity in protein-protein interactions. Their DiffuseSandbox app allows researchers to interactively explore these capabilities, even without a computational background, democratizing access to advanced protein design tools.

Diffuse Bio’s approach eliminates the need for time-intensive lab-in-the-loop screening by delivering performant designs on the first iteration. Their integrated software stack and proprietary assays enable the collection of experimental data at scale, further powering the next generation of AI models. The company measures its success through computational benchmarks, internal case studies, and the realization of commercial goals with partners.

With a mission to revolutionize protein therapeutics and other protein-based innovations, Diffuse Bio is committed to open collaboration, continuous improvement, and expanding the boundaries of what’s possible in protein engineering through AI.